Supply chain gaps analysis during COVID-19 pandemic - the case of medical supplies in Tanzania

Abstract

Purpose: This study aims to investigate the supply chain gaps during the COVID-19 pandemic in Tanzania amid the pandemic era. Design/methodology/approach: This study adopted a mixed approach, using both structured questionnaires and individual interviews to gather raw data (quantitative and qualitative data). To assess quantitative data for statistical (descriptive and inferential) analysis, this study used a sample of 57 wholesale and retail pharmacies and 10 hospital pharmacies, which were randomly selected. The thematic analysis was applied to the gathered qualitative data to authenticate the quantitative findings and conclusions which were the outcome of the descriptive and inferential analysis (binary logistics regression) analysed by the SPSS. Findings: The results revealed the presence of various supply chain gaps in terms of target gaps, time gaps and coverage gaps. This study highlighted the disruption on demand and uncertainty in business environment as ways that the COVID-19 pandemic contributed to the gaps and revealed the negative effects of the supply chain gaps on the effectiveness of medical supplies in Tanzania. Research limitations/implications: The results revealed the presence of various supply chain gaps (in terms of target gaps, time gaps and coverage gaps), underlined the disruption in demand and uncertainty in the business environment as ways that the COVID-19 pandemic contributed to the gaps and revealed the negative effects of the supply chain gaps on the effectiveness of medical supplies in Tanzania. Practical implications: Data generated and used in this study is from participants from one country only (Tanzania), despite the supply chain gaps being common to many developing countries in general. Originality/value: This study provides a novel framework in medical supply chain literature by identifying numerous disruptions in the medical supply chain which emerged during the COVID-19 emergence and serves as a basis for future studies on how to counter the gaps and rebuild a resilient and sustainable medical supply chain in developing countries.